|
| Status |
Public on Apr 08, 2016 |
| Title |
Regulatory T cell modulation by CBP/EP300 bromodomain inhibition |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
27056325 |
| Submission date |
Jul 09, 2015 |
| Last update date |
May 15, 2019 |
| Contact name |
Barbara M Bryant |
| E-mail(s) |
barbara.bryant@constellationpharma.com
|
| Organization name |
Constellation Pharmaceuticals
|
| Street address |
215 First Street
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02142 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL5175 |
[HuEx-1_0-st] Affymetrix Human Exon 1.0 ST Array [transcript (gene) version] |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (16)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE66596 |
Regulatory T cell modulation by CBP/EP300 bromodomain inhibition [array] |
| GSE70620 |
Regulatory T cell modulation by CBP/EP300 bromodomain inhibition [RNA-seq] |
| GSE70708 |
Regulatory T cell modulation by CBP/EP300 bromodomain inhibition [ChIP-seq] |
|
| Relations |
| BioProject |
PRJNA289403 |
Less...
More...